<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="758d66fb-0447-4f26-905f-595b182aebdc"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use RIVFLOZA safely and effectively.  See full prescribing information for RIVFLOZA.<br/>RIVFLOZA<sup>®</sup> (nedosiran) injection, for subcutaneous use<br/>Initial U.S. Approval: 2023</title>
   <effectiveTime value="20250303"/>
   <setId root="ace9d4bc-4d20-4beb-9e9d-888690424833"/>
   <versionNumber value="4"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="622920320" root="1.3.6.1.4.1.519.1"/>
            <name>Novo Nordisk</name>
            <assignedEntity>
               <assignedOrganization/>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="7c1a2f4d-82ba-4287-ab09-fa55dcd12388"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20230929"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0169-5306" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>RIVFLOZA</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>nedosiran</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator unit="mg" value="160"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="EGR9KYM536" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>NEDOSIRAN SODIUM</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="13U9R5J3WL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>NEDOSIRAN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0169-5306-10" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20240219"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA215842" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20240219"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0169-5307" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>RIVFLOZA</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>nedosiran</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator unit="mg" value="128"/>
                              <denominator unit="mL" value="0.8"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="EGR9KYM536" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>NEDOSIRAN SODIUM</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="13U9R5J3WL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>NEDOSIRAN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="0.8"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43202" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SYRINGE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0169-5307-08" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20240219"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102835" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA215842" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20240219"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0169-5308" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>RIVFLOZA</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>nedosiran</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator unit="mg" value="80"/>
                              <denominator unit="mL" value="0.5"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="EGR9KYM536" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>NEDOSIRAN SODIUM</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="13U9R5J3WL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>NEDOSIRAN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="CNTM">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="0.5"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43226" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0169-5308-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20240219"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA215842" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20240219"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUBCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID_7fe402bd-41a1-47ce-bf27-70115814ea86">
               <id root="8a0f29c6-96d7-4b18-aa2b-8c755d010c01"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE </title>
               <text>
                  <paragraph>RIVFLOZA is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥30 mL/min/1.73 m<sup>2 </sup>
                     <content styleCode="italics">[see Clinical Pharmacology (‎<linkHtml href="#ID_3e12d376-a0d0-48e7-a2ca-6ce415aa1844">12.3</linkHtml>)], Clinical Studies (‎<linkHtml href="#ID_69b0ec7b-5d47-4d59-9d05-4e470ee56f0a">14.1</linkHtml>)].</content>
                  </paragraph>
               </text>
               <effectiveTime value="20250303"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>RIVFLOZA is an <content styleCode="italics">LDHA</content>-directed small interfering RNA indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥30 mL/min/1.73 m<sup>2</sup>. (‎<linkHtml href="#ID_7fe402bd-41a1-47ce-bf27-70115814ea86">1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_7d52e57e-d0f0-4f5a-9041-e3eee2215413">
               <id root="39d21db3-93d8-4a1b-b866-870d6a310c4b"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION </title>
               <effectiveTime value="20250303"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>The recommended dosage is shown below and is administered subcutaneously once monthly. (‎<linkHtml href="#ID_04dcae77-f4fe-45e1-84e0-1e6bc7d42fed">2.1</linkHtml>)</paragraph>
                        <table width="256.25pt">
                           <col width="15%"/>
                           <col width="13%"/>
                           <col width="13%"/>
                           <col width="12%"/>
                           <tbody>
                              <tr>
                                 <td rowspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <td align="center" colspan="3" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Body weight</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Less than 39 kg</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">39 kg to less than 50 kg</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">50 kg and above</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Age 2 to less than 12 years</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>3.3 mg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>128 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>160 mg</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Age 12 years and older</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>128 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>160 mg</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>See full Prescribing Information for important administration instructions. (‎<linkHtml href="#ID_04dcae77-f4fe-45e1-84e0-1e6bc7d42fed">2.2</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_04dcae77-f4fe-45e1-84e0-1e6bc7d42fed">
                     <id root="ba2c7964-0f29-4747-8cc6-eea1e0ed3a7f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 Recommended Dosage </title>
                     <text>
                        <paragraph>RIVFLOZA is administered subcutaneously once monthly at the recommended doses shown in <content styleCode="bold">Table 1</content>.</paragraph>
                        <paragraph>Dosing is based on actual body weight.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Table 1: RIVFLOZA Dose Regimen in Adults and Pediatric Patients (2 years of age and older)</content>
                        </paragraph>
                        <table width="476.75pt">
                           <col width="11%"/>
                           <col width="28%"/>
                           <col width="35%"/>
                           <col width="25%"/>
                           <tbody>
                              <tr>
                                 <td rowspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="middle"/>
                                 <td align="center" colspan="3" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Body weight</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Less than 39 kg</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">39 kg to less than 50 kg</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">50 kg and above</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Lrule Botrule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Age 2 to less than 12 years</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>3.3 mg/kg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>128 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <paragraph>160 mg</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>
                                       <content styleCode="bold">Age 12 years and older</content>
                                    </paragraph>
                                 </td>
                                 <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>128 mg</paragraph>
                                 </td>
                                 <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="middle">
                                    <paragraph>160 mg</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="underline">Missed Dose</content>
                        </paragraph>
                        <paragraph>If a planned dose is missed, administer RIVFLOZA as soon as possible. If the planned dose is missed by more than 7 days, administer RIVFLOZA as soon as possible and resume monthly dosing from the most recently administered dose.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_35d7168a-efeb-43bf-8e39-a7159d06321c">
                     <id root="fd4db712-f55d-4fa3-8c82-e1de9f1b22ed"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Administration Instructions </title>
                     <text>
                        <paragraph>Pre-filled syringe: A healthcare provider, caregiver, or patient 12 years of age and older may inject RIVFLOZA using the pre-filled syringe. In pediatric patients 2 to less than 12 years of age who weigh ≥39 kg, a healthcare provider or caregiver may inject RIVFLOZA using the pre-filled syringe.</paragraph>
                        <paragraph>Vials: RIVFLOZA vials are intended for use under the guidance and supervision of a healthcare provider. Adult patients or caregivers may administer RIVFLOZA after proper training in preparing RIVFLOZA vials for administration, if a healthcare provider determines that it is appropriate, and with medical follow-up as necessary.</paragraph>
                        <paragraph>Administer RIVFLOZA by subcutaneous injection to the abdomen (at least 2 inches from the navel) or the upper thigh. Do not inject into a vein or into scarred or bruised skin.</paragraph>
                        <paragraph>Inspect visually for particulate matter and discoloration prior to injection. RIVFLOZA should be colorless-to-yellow and particle free. If the solution is cloudy or contains particulate matter, do not use.</paragraph>
                        <paragraph>Instructions for delivering the dosage are provided in the Instructions for Use leaflets enclosed with the RIVFLOZA Pre-filled Syringe and single-dose vial.</paragraph>
                        <paragraph>Discard the unused portion of the drug.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_5fb489fe-aad8-4888-81e2-2220638c585f">
               <id root="b8957ec1-4ce6-48f7-921c-df8a802dda90"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS </title>
               <text>
                  <paragraph>RIVFLOZA Injection 160 mg/mL (present as 170 mg nedosiran sodium) is a clear, colorless-to-yellow solution available as follows:</paragraph>
                  <list listType="unordered">
                     <item>
                        <caption>•</caption>80 mg/0.5 mL single-dose vial</item>
                     <item>
                        <caption>•</caption>128 mg/0.8 mL single-dose Pre-filled Syringe</item>
                     <item>
                        <caption>•</caption>160 mg/ mL single-dose Pre-filled Syringe</item>
                  </list>
               </text>
               <effectiveTime value="20250303"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>RIVFLOZA Injection 160 mg/mL is a clear, colorless-to-yellow solution available as follows:</paragraph>
                        <list listType="unordered">
                           <item>
                              <caption>•</caption>80 mg/0.5 mL single-dose vial</item>
                           <item>
                              <caption>•</caption>128 mg/0.8 mL single-dose Pre-filled Syringe </item>
                           <item>
                              <caption>•</caption>160 mg/ mL single-dose Pre-filled Syringe (‎<linkHtml href="#ID_5fb489fe-aad8-4888-81e2-2220638c585f">3</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_c82a8060-48f0-4433-b7da-a6e71c428e4f">
               <id root="c82a8060-48f0-4433-b7da-a6e71c428e4f"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS </title>
               <text>
                  <paragraph>None.</paragraph>
               </text>
               <effectiveTime value="20230929"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>None. (<linkHtml href="#ID_c82a8060-48f0-4433-b7da-a6e71c428e4f">4</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="ID_e0f7f8dd-6df8-42ec-9dc2-579edafb7c64">
               <id root="ed7ed87c-2f40-49f5-b775-bd9b78ebcffc"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS </title>
               <effectiveTime value="20250303"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Most common adverse reactions (reported in ≥20% of patients) are injection site reactions. (‎<linkHtml href="#ID_dd60820d-4b0e-474f-8040-f53b3ec48079">6.1</linkHtml>)</paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact </content>
                           <content styleCode="bold">Novo Nordisk Inc. at 1-844-906-5099</content>
                           <content styleCode="bold"> or FDA at 1-800-FDA-1088 or <linkHtml href="http://www.fda.gov/medwatch">www.fda.gov/medwatch.</linkHtml>
                           </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="ID_dd60820d-4b0e-474f-8040-f53b3ec48079">
                     <id root="bfe6bbb7-0953-436b-b1b0-bb8348c9ac11"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.1 Clinical Trials Experience </title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.</paragraph>
                        <paragraph>The safety of RIVFLOZA has been evaluated in one placebo-controlled clinical trial (PHYOX2) and one open-label extension study (PHYOX3). Across these studies, 29 adults and 12 children with PH1 have been treated with RIVFLOZA. Patients with PH1 in these studies ranged in age from 9 to 46 years at first dose. The median duration of exposure was approximately 15 months (range 1-29 months). Overall, 38 patients with PH1 were treated for at least 6 months, 24 patients for at least 12 months, and 16 patients for at least 18 months.</paragraph>
                        <paragraph>In the randomized, placebo-controlled, double-blind PHYOX2 trial in pediatric and adult patients 9 to 46 years of age, 18 patients with PH1 received RIVFLOZA and 11 patients received placebo. Of the 18 patients treated with RIVFLOZA, 17 patients received ≥5 months of active treatment. The most common adverse reactions were injection site reactions, which were reported in 7 patients with PH1 (39%) on RIVFLOZA as compared to no patients on placebo. Injection site reactions included erythema, pain, bruising, and rash and were generally mild and did not lead to discontinuation of treatment. </paragraph>
                        <paragraph>In the single-arm extension study (PHYOX3) that included 40 patients with PH1, additional injection site reactions included atrophy in 1 patient (3%).</paragraph>
                        <paragraph>The safety of RIVFLOZA has additionally been evaluated in one single-arm clinical study (PHYOX8) in 15 pediatric patients 2 to less than 12 years of age with PH1 and an eGFR <content styleCode="underline">&gt;</content>30 mL/min/1.73 m<sup>2</sup>. Injection site reactions were reported in 2 patients (13%). Overall, the RIVFLOZA safety profile was similar to that seen in PHYOX2.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_993cea1d-4332-49e5-a329-b9670b88501e">
               <id root="10a6990c-0312-4ef1-88c5-6d8807ffe715"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS </title>
               <effectiveTime value="20250303"/>
               <component>
                  <section ID="ID_17bc0617-66f2-407f-89a4-1f367bddd43a">
                     <id root="a2c36c9d-8fc2-4ef7-93b1-34f21f461bf4"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>Available data from reports of pregnancy in clinical trials with RIVFLOZA are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. </paragraph>
                        <paragraph>In animal reproduction studies, no adverse developmental effects were observed when nedosiran was administered to pregnant mice at doses up to approximately 58 times the maximum recommended human dose (MRHD) of 160 mg nedosiran (equivalent to 170 mg nedosiran sodium) per dose, based on body surface area (BSA) or upon administration of a mouse-specific (pharmacologically active) analog. Subcutaneous administration of nedosiran to pregnant rabbits during the period of organogenesis at doses approximating the MRHD resulted in increased fetal loss in the presence of maternal toxicity. Adverse developmental outcomes (fetal cardiovascular and skeletal malformations) were observed at a dose approximately 2 times the MRHD <content styleCode="italics">(see Data).</content> Nedosiran is not pharmacologically active in rabbits or mice. The cause for the embryo-fetal toxicities observed in rabbits remains unclear.</paragraph>
                        <paragraph>The estimated background risk of major birth defects and miscarriage in the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Data</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="italics">Animal Data</content>
                        </paragraph>
                        <paragraph>In mice, subcutaneous administration of nedosiran at doses up to 2000 mg/kg/dose (approximately 58 times the MRHD based on BSA) or a mouse-specific (pharmacologically active) analog (10 mg/kg/dose) during organogenesis (dosing on gestation days 6, 8, 10, 12, and 14 for nedosiran; gestation days 3 and 10 for the analog) did not have adverse effects on embryo-fetal development.</paragraph>
                        <paragraph>Subcutaneous administration of nedosiran (0, 2, 6 or 20 mg/kg/dose) to pregnant rabbits during organogenesis (dosing on gestation days 7, 9, 11, 13, 15, 17, and 19) resulted in maternal toxicity on the basis of body weight loss of up to 6.5% following the first dose in the 6 and 20 mg/kg/dose groups. Higher post-implantation loss and lower numbers of live fetuses occurred at ≥6 mg/kg/dose (exposures equivalent to the MRHD based on BSA), and fetal cardiovascular and skeletal malformations occurred at the 20 mg/kg/dose (2 times the MRHD based on BSA). At the 2 mg/kg/dose, which is below the MRHD, no adverse findings were seen.</paragraph>
                        <paragraph>In a pre- and postnatal study in mice, subcutaneous administration of nedosiran (0, 250, 500, or 1000 mg/kg/dose) or a mouse-specific (pharmacologically active) analog (10 mg/kg/dose) from implantation (dosing on gestational days 6, 8, 10, 12, 14, 16) to weaning (dosing on lactation days 1, 8, 15, 20) did not have adverse effects on the growth, viability, development and reproductive performance of the offspring<content styleCode="italics">.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_81c1986e-e2ee-4812-9958-ee82e23b72ab">
                     <id root="81c1986e-e2ee-4812-9958-ee82e23b72ab"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation </title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                        </paragraph>
                        <paragraph>There are no data on the presence of RIVFLOZA in human or animal milk, the effects on the breastfed child, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for RIVFLOZA and any potential adverse effects on the breastfed infant from RIVFLOZA or from the underlying maternal condition.</paragraph>
                     </text>
                     <effectiveTime value="20230929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_75884df2-208f-4deb-81d8-be4a38e89741">
                     <id root="7ce1bbb0-9d85-4a41-bb37-30493062e1b0"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use </title>
                     <text>
                        <paragraph>The safety and effectiveness of RIVFLOZA have been established in pediatric patients aged 2 years and older. Use of RIVFLOZA in these age groups is supported by evidence from an adequate and well-controlled trial in adult and pediatric patients 9 years of age and older (PHYOX2), and a single-arm study in pediatric patients 2 to less than 12 years of age (PHYOX8) <content styleCode="italics">[see Clinical Studies (</content>
                           <content styleCode="italics">‎<linkHtml href="#ID_763bda39-6447-4ab4-af9b-ee793b8a5231">14</linkHtml>)]</content>. </paragraph>
                        <paragraph>The safety and effectiveness of RIVFLOZA in patients younger than 2 years of age have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_4a336c34-4aa4-4f85-8400-2bd3054356b1">
                     <id root="bc52f87b-0366-4133-beb0-1b54cf3e4eda"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use </title>
                     <text>
                        <paragraph>Clinical studies of RIVFLOZA did not include patients aged 65 and over to determine whether they respond differently from younger patients. No dose adjustment is recommended in patients ≥65 years old <content styleCode="italics">[see Clinical Pharmacology (‎<linkHtml href="#ID_3e12d376-a0d0-48e7-a2ca-6ce415aa1844">12.3</linkHtml>)].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_061e7fd5-d82e-4b2a-82ce-f6f01617258d">
                     <id root="7518050a-794c-4dab-b0d1-473ebe2e5c80"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.6 Hepatic Impairment </title>
                     <text>
                        <paragraph>No dose adjustment of RIVFLOZA is recommended for patients with mild hepatic impairment (total bilirubin ≤ upper limit of normal [ULN] and aspartate aminotransferase [AST] &gt; ULN or total bilirubin &gt;1 to 1.5 times ULN and any AST). </paragraph>
                        <paragraph>RIVFLOZA has not been studied in patients with moderate or severe hepatic impairment (total bilirubin &gt;1.5 ULN with any AST) <content styleCode="italics">[see Clinical Pharmacology (</content>
                           <content styleCode="italics">‎<linkHtml href="#ID_3e12d376-a0d0-48e7-a2ca-6ce415aa1844">12.3</linkHtml>)]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_6231858d-1e78-4f9c-80cf-92d69b422075">
                     <id root="85505aeb-483d-4f43-8e4e-f37e7e0ef2c6"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>8.7 Renal Impairment </title>
                     <text>
                        <paragraph>No dose adjustment is recommended in patients with an estimated glomerular filtration rate (eGFR) of ≥30 mL/min/1.73 m<sup>2 </sup>
                           <content styleCode="italics">[see Clinical Pharmacology (‎<linkHtml href="#ID_3e12d376-a0d0-48e7-a2ca-6ce415aa1844">12.3</linkHtml>)]</content>.</paragraph>
                        <paragraph>RIVFLOZA has not been studied in PH1 patients with severe renal impairment (eGFR &lt;30 mL/min/1.73 m<sup>2</sup>).</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_62c61615-f472-4388-94e4-c1c068aef430">
               <id root="077d86f7-54fd-4475-88f8-2c14b4602b0d"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION </title>
               <text>
                  <paragraph>RIVFLOZA injection contains nedosiran, a double-stranded small interfering RNA (siRNA) with four covalently attached <content styleCode="italics">N</content>-acetyl-D-galactosamine (GalNAc) residues. Nedosiran targets lactate dehydrogenase A (LDHA) in hepatocytes via GalNAc-mediated delivery.</paragraph>
                  <paragraph>The structural formula of the nedosiran sodium drug substance is presented below:</paragraph>
                  <renderMultiMedia ID="id692111579" referencedObject="ID_7cf4e13f-afc6-459c-8717-c7498ad54535"/>
                  <paragraph>The molecular formula of nedosiran sodium is C<sub>662</sub>H<sub>808</sub>F<sub>19</sub>N<sub>231</sub>O<sub>413</sub>P<sub>57</sub>S<sub>6</sub>Na<sub>57</sub> with a molecular weight of 22,238 Da. Nedosiran sodium is freely soluble in water.</paragraph>
                  <paragraph>RIVFLOZA Pre-filled Syringe is supplied as a clear, sterile, preservative-free, colorless‑to‑yellow solution for subcutaneous injection containing either the equivalent of 160 mg (present as 170 mg nedosiran sodium salt) nedosiran in 1 mL or the equivalent of 128 mg (present as 136 mg nedosiran sodium salt) nedosiran in 0.8 mL of water for injection and sodium hydroxide and/or hydrochloric acid to adjust the pH to ~7.2.</paragraph>
                  <paragraph>RIVFLOZA vial is supplied as a clear, sterile, preservative-free, colorless-to-yellow solution for subcutaneous injection containing the equivalent of 80 mg (present as 85 mg nedosiran sodium salt) nedosiran in 0.5 mL of water for injection and sodium hydroxide and/or hydrochloric acid to adjust the pH to ~7.2.</paragraph>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="ID_7cf4e13f-afc6-459c-8717-c7498ad54535">
                     <text>structural_formula</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="structural-formula.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_110649c6-e51f-4e2c-8260-efa542b734d7">
               <id root="0c79e7d9-0c18-471a-a2cf-11d6e42df40b"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY </title>
               <effectiveTime value="20250303"/>
               <component>
                  <section ID="ID_551bd8a3-751a-47d9-87fc-a3466c4b65f0">
                     <id root="551bd8a3-751a-47d9-87fc-a3466c4b65f0"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action </title>
                     <text>
                        <paragraph>Nedosiran is a double-stranded siRNA, conjugated to GalNAc aminosugar residues. After subcutaneous administration, the GalNAc-conjugated sugars bind to asialoglycoprotein receptors (ASGPR) to deliver nedosiran to hepatocytes.</paragraph>
                        <paragraph>Nedosiran reduces levels of hepatic lactate dehydrogenase (LDH) via the degradation of LDHA messenger ribonucleic acid (mRNA) in hepatocytes through RNA interference. The reduction of hepatic LDH by nedosiran reduces the production of oxalate by the liver, thereby reducing subsequent oxalate burden.</paragraph>
                     </text>
                     <effectiveTime value="20230929"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_e57d5d53-702a-4798-95d0-f669166a72b9">
                     <id root="e7aa432c-8c09-4a82-90d4-f7e82cb168aa"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics </title>
                     <text>
                        <paragraph>The pharmacodynamic effects of RIVFLOZA were evaluated after single-dose and monthly-dose administration in patients with PH1. Dose-dependent reductions in urinary oxalate were observed in the single-dose range of 1.5 mg/kg to 6.0 mg/kg. With the recommended monthly dose regimen of RIVFLOZA, onset of effect was observed at the first measurement (30 days after the first dose) and the effect persisted with continued monthly dosing <content styleCode="italics">[see Clinical Studies (</content>
                           <content styleCode="italics">‎<linkHtml href="#ID_69b0ec7b-5d47-4d59-9d05-4e470ee56f0a">14.1</linkHtml>)]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Cardiac Electrophysiology </content>
                        </paragraph>
                        <paragraph>At the recommended dose, RIVFLOZA does not lead to clinically relevant QT interval prolongation.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_3e12d376-a0d0-48e7-a2ca-6ce415aa1844">
                     <id root="5d33bbd9-0920-451d-be1d-2d28c18f0513"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics </title>
                     <text>
                        <paragraph>The pharmacokinetic (PK) properties of RIVFLOZA were evaluated following administration of single and multiple dosages in patients with PH1 or PH2 as summarized in <content styleCode="bold">Table 2</content>.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Table 2: Pharmacokinetic Parameters of Nedosiran</content>
                        </paragraph>
                        <table cellpadding="0pt" width="481.45pt">
                           <col width="13%"/>
                           <col width="22%"/>
                           <col width="64%"/>
                           <tbody>
                              <tr>
                                 <td colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">Nedosiran</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>
                                       <content styleCode="bold">General Information</content>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td rowspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Steady State Exposure</paragraph>
                                 </td>
                                 <td align="justify" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>C<sub>max</sub> [Mean (%CV)]</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>844 (44) ng/mL</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>AUC<sub>0-last </sub>[Mean (%CV)]</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                                    <list listType="ordered">
                                       <item>
                                          <caption> </caption>13600 (36) ng<sup>*</sup>h/mL</item>
                                    </list>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Dose Proportionality</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Nedosiran exhibited a dose-proportional increase in plasma exposure following single subcutaneous doses from 1.5 to 6.0 mg/kg.</paragraph>
                                    <paragraph>Nedosiran exhibited time-independent pharmacokinetics with multiple doses of 160 mg once monthly (body weight ≥50 kg), 128 mg once monthly (body weight &lt;50 kg), or 3.3 mg/kg once monthly in the age range of 6 to 11 years. </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Accumulation</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>No accumulation of nedosiran was observed in plasma following repeated monthly dosing.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Absorption</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>T<sub>max</sub> [Median (Range)]</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>6 (2 to 12) hours</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Distribution<sup>a</sup>
                                    </paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Estimated Vz/F</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>126 L</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Protein Binding</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>85.6%</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Elimination</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Half-Life (Mean (%CV)])</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>15 (68) hours</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Estimated CL/F</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>5.7 L/hr</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Metabolism</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Primary Pathway</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Nedosiran is metabolized by endo- and exonucleases to shorter oligonucleotides.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Excretion</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Primary Pathway</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>Approximately 27% of the administered nedosiran dose is excreted unchanged into the urine within 24 hours of dosing.</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td colspan="3" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>
                                       <sup>a</sup> Nedosiran distributes primarily to the liver after subcutaneous administration.</paragraph>
                                    <paragraph>C<sub>max</sub> = maximum plasma concentration; AUC<sub>0-last</sub> = area under the plasma concentration-time curve from time of administration (0) to the last measurable time point (last); T<sub>max</sub> = time to maximum concentration; Vz/F = apparent volume of distribution; CV = coefficient of variation; CL/F = apparent clearance.</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="underline">Specific Populations</content>
                        </paragraph>
                        <paragraph>No clinically significant differences in the pharmacokinetics or pharmacodynamics of nedosiran were observed based on age (2 to 73 years old), sex, race/ethnicity, mild-to-moderate renal impairment (eGFR 30 to 89 mL/min/1.73 m<sup>2</sup>) <content styleCode="italics">[see Use in Specific Populations (</content>
                           <content styleCode="italics">‎<linkHtml href="#ID_6231858d-1e78-4f9c-80cf-92d69b422075">8.7</linkHtml>
                           </content>)<content styleCode="italics">]</content> or mild hepatic impairment as assessed using the National Cancer Institute Organ Dysfunction Working Group criteria (total bilirubin ≤ ULN and AST &gt; ULN; or total bilirubin &gt;1 to 1.5 × ULN and any AST) <content styleCode="italics">[see Use in Specific Populations (</content>
                           <content styleCode="italics">‎<linkHtml href="#ID_061e7fd5-d82e-4b2a-82ce-f6f01617258d">8.6</linkHtml>)]</content>.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Pediatrics: </content>
                        </paragraph>
                        <paragraph>At the recommended clinical dose, PK exposure of nedosiran is similar in adult and pediatric patients 2 years of age and older.</paragraph>
                        <paragraph>
                           <content styleCode="underline">Drug Interaction Studies </content>
                        </paragraph>
                        <paragraph>Concomitant use of pyridoxine (vitamin B6) did not have a significant impact on the PK of nedosiran. </paragraph>
                        <paragraph>In vitro studies demonstrated that nedosiran was not an inhibitor or inducer of cytochrome P450 (CYP) enzymes and was neither a substrate nor an inhibitor of efflux and uptake transporters.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_eee6f719-399c-4226-8861-61f89065ca7c">
                     <id root="34e18c4a-aede-4d35-b5f3-4fbfa9c81952"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>12.6 Immunogenicity </title>
                     <text>
                        <paragraph>As with all oligonucleotides, including RIVFLOZA, there is a potential for immunogenicity. The detection of antibody formation is highly dependent on the sensitivity and specificity of the assay. Additionally, the observed incidence of antibody positivity in an assay may be influenced by several factors, including assay methodology, sample handling, timing of sample collection, concomitant medications, and underlying disease. For these reasons, comparison of the incidence of antibodies in the studies described below with the incidence of antibodies in other studies or to other products may be misleading. </paragraph>
                        <paragraph>Across all clinical studies in the nedosiran development program, including patients with PH1 dosed with RIVFLOZA, RIVFLOZA did not induce or boost anti-drug antibodies (ADA). Among 79 patients tested with the ADA assay, none developed treatment-emergent ADA.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_389d1f66-da0f-4ae4-9688-4e288df1913e">
               <id root="389d1f66-da0f-4ae4-9688-4e288df1913e"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY </title>
               <effectiveTime value="20230929"/>
               <component>
                  <section ID="ID_da8844e4-e155-48d4-80bb-f9bbdc131c27">
                     <id root="da8844e4-e155-48d4-80bb-f9bbdc131c27"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility </title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Carcinogenicity</content>
                        </paragraph>
                        <paragraph>Long-term studies to assess carcinogenic risk of nedosiran have not been conducted.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Genotoxicity</content>
                        </paragraph>
                        <paragraph>Nedosiran was not genotoxic in the in vitro bacterial mutagenicity, in vitro micronucleus assays (human peripheral blood lymphocytes) and in vivo bone marrow micronucleus assay in mice.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Fertility</content>
                        </paragraph>
                        <paragraph>Weekly subcutaneous administration of nedosiran at doses of 500, 1000, or 2000 mg/kg or of a mouse-specific (pharmacologically active) analog at a dose of 10 mg/kg to male mice for 4 weeks prior to and throughout mating, and to female mice for 2 weeks prior to and throughout mating and to gestation day 7 did not affect male or female fertility or early embryonic development.</paragraph>
                     </text>
                     <effectiveTime value="20230929"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_763bda39-6447-4ab4-af9b-ee793b8a5231">
               <id root="2bf47450-c431-4276-be17-620e115f0bdb"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES </title>
               <effectiveTime value="20250303"/>
               <component>
                  <section ID="ID_69b0ec7b-5d47-4d59-9d05-4e470ee56f0a">
                     <id root="b0d3efca-5b86-40de-b678-831f5a2b6a05"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1 PHYOX2 </title>
                     <text>
                        <paragraph>PHYOX2 was a randomized, double-blind trial comparing RIVFLOZA and placebo in patients aged 6 years or older with PH1 or PH2 and an eGFR ≥ 30 mL/min/1.73 m<sup>2</sup> (NCT03847909). Too few PH2 patients were enrolled to evaluate efficacy in the PH2 population. Therefore, RIVFLOZA is only indicated for patients with PH1 <content styleCode="italics">[see Indications and Usage (1)]. </content>Unless otherwise noted, data are presented for the complete study population (PH1 and PH2).</paragraph>
                        <paragraph>Patients received monthly doses of RIVFLOZA (N=23) or placebo (N=12). The RIVFLOZA dose for patients at least 12 years of age weighing at least 50 kg was 160 mg, for patients at least 12 years of age weighing less than 50 kg was 128 mg, and for children 6 to 11 years of age was 3.3 mg/kg (to a maximum of 128 mg).</paragraph>
                        <paragraph>The median age was 20 years (range 9 - 46 years), 51% were female, 71% were White, 17% were Asian, 83% had PH1, and 17% had PH2. At baseline, mean 24-hour urinary oxalate excretion, normalized by 1.73 m<sup>2</sup> BSA in patients less than 18 years of age, was 1547 µmol/24‑hour. Mean plasma oxalate was 8.2 µmol/L, 43% of patients had an eGFR ≥ 90 mL/min/1.73 m<sup>2</sup>, 34% had an eGFR 60 to &lt; 90 mL/min/1.73 m<sup>2</sup>, 23% had an eGFR 30 to &lt; 60 mL/min/1.73 m<sup>2</sup>, and 60% were taking pyridoxine.</paragraph>
                        <paragraph>The primary efficacy endpoint was the area under the curve, from Days 90 to 180, of the percent change from baseline in 24-hour urinary oxalate excretion (AUC<sub>24-hour Uox</sub>). The least-squares (LS) mean AUC<sub>24‑hour Uox</sub> was -3486 (95% CI: -5025, -1947) in the RIVFLOZA group compared to 1490 (95% CI: 781, 3761) in the placebo group, for a between group difference of 4976 (95% CI: 2803, 7149; p&lt;0.0001).</paragraph>
                        <paragraph>The LS mean percent change from baseline in 24-hour urinary oxalate excretion (corrected for BSA in patients &lt; 18 years of age) averaged over Days 90, 120, 150 and 180, was -37% (95% CI: -53%, -21%) in the RIVFLOZA group and 12% (95% CI: ‑12%, 36%) in the placebo group, for a between group difference of 49% (95% CI: 26%, 72%) [<content styleCode="bold">Figure 1</content>]. Among patients with PH1, the between group difference was 56% (95% CI: 33%, 80%).</paragraph>
                        <paragraph>
                           <content styleCode="bold">Figure 1. Mean (95% CI) Percent Change from Baseline in 24-hour Urinary Oxalate in RIVFLOZA and Placebo-Treated Patients in PHYOX2</content>
                        </paragraph>
                        <renderMultiMedia ID="id1654564519" referencedObject="ID_323629b7-ad2e-4ea2-a4c0-410baff0f53a"/>
                        <paragraph>After 6 months of treatment in PHYOX2, patients could enroll in an ongoing single-arm extension study, PHYOX3 (NCT04042402), in which all patients were treated with RIVFLOZA. The reduction in urinary oxalate was maintained in the 13 patients with PH1 who received an additional 6 months of treatment in PHYOX3.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                     <component>
                        <observationMedia ID="ID_323629b7-ad2e-4ea2-a4c0-410baff0f53a">
                           <text>figure_1</text>
                           <value mediaType="image/jpeg" xsi:type="ED">
                              <reference value="figure_1.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="ID_e5142380-ba5b-4d5a-9f4e-b3e7caa36f3b">
                     <id root="6cb0f1a7-ef1c-48b9-82f4-353a847ed476"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2 PHYOX8 </title>
                     <text>
                        <paragraph>PHYOX8 (NCT05001269) was a single-arm open-label multicenter study that included patients 2 years of age to less than 12 years of age with PH1 and an eGFR <content styleCode="underline">&gt;</content>30 mL/min/1.73 m<sup>2</sup>.</paragraph>
                        <paragraph>The median age of patients at first dose was 5 years (range 2 to 10 years), 33% were female, and 80% were White. A total of 15 patients with PH1 completed treatment; 8 patients were 2 to less than 6 years of age, 5 patients were 6 to less than 9 years of age and 2 patients were 9 to 11 years of age. The mean spot urinary oxalate:creatinine ratio at baseline was 0.36 mmol/mmol. </paragraph>
                        <paragraph>The primary endpoint was the percent change from baseline in spot urinary oxalate:creatinine ratio at Month 6. Patients treated with RIVFLOZA had a 64% (95% CI: 44, 84) reduction in spot urinary oxalate:creatinine ratio from baseline at Month 6 (<content styleCode="bold">Figure 2</content>). The corresponding absolute reduction in spot urinary oxalate:creatinine ratio at Month 6 was 0.25 mmol/mmol (95% CI: 0.21, 0.29).</paragraph>
                        <paragraph>
                           <content styleCode="bold">Figure 2. PHYOX8: Mean (95% CI) Percent Change in Spot Urinary Oxalate: Creatinine Ratio from Baseline by Month</content>
                        </paragraph>
                        <content styleCode="bold">
                           <renderMultiMedia ID="id431562471" referencedObject="ID_72d33d56-86ec-4038-86e5-3f2a6c1323cf"/>
                        </content>
                        <paragraph>After 6 months of treatment in PHYOX8, patients could enroll in an ongoing single arm extension study, PHYOX3. The reduction in urinary oxalate:creatinine ratio was maintained in the 8 patients who received an additional 6 months of treatment in PHYOX3.</paragraph>
                     </text>
                     <effectiveTime value="20250303"/>
                     <component>
                        <observationMedia ID="ID_72d33d56-86ec-4038-86e5-3f2a6c1323cf">
                           <text>figure-2</text>
                           <value mediaType="image/jpeg" xsi:type="ED">
                              <reference value="figure-2.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_6ec4ef27-2f82-4c16-b53e-54449854df3e">
               <id root="752c2415-97a0-4bc4-8850-8480653df57a"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING </title>
               <effectiveTime value="20250303"/>
               <component>
                  <section ID="ID_d7c16514-f81d-4497-9cde-67c93677ecc9">
                     <id root="34bdebb0-93a6-4846-b369-7198badab770"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>16.1 How Supplied </title>
                     <text>
                        <paragraph>RIVFLOZA is a clear, sterile, preservative-free, colorless-to-yellow solution available in single-dose pre-filled syringes and single-dose vials in cartons containing one unit each.</paragraph>
                        <list listType="ordered">
                           <item>
                              <caption> </caption>
                              <content styleCode="bold">Table 3: RIVFLOZA Presentations</content>
                           </item>
                        </list>
                        <table width="423pt">
                           <col width="20%"/>
                           <col width="10%"/>
                           <col width="17%"/>
                           <col width="17%"/>
                           <col width="25%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>RIVFLOZA Presentation</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Total Volume</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Total amount available in presentation </paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Concentration </paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>NDC number</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Single-dose vial</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.5 mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>80 mg</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>160 mg/mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0169-5308-01</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Lrule Botrule " valign="top">
                                    <paragraph>Single-dose</paragraph>
                                    <paragraph>Pre-filled Syringe</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>0.8 mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>128 mg</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>160 mg/mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                                    <paragraph>NDC 0169-5307-08</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>Single-dose</paragraph>
                                    <paragraph>Pre-filled Syringe</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>1 mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>160 mg</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>160 mg/mL</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                                    <paragraph>NDC 0169-5306-10</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_4232ee18-7b2d-4dc9-9277-c733126720b1">
                     <id root="7a7a0307-2133-45d3-a8b1-291dc42b78cd"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>16.2 Storage and Handling </title>
                     <text>
                        <paragraph>Store refrigerated at 2°C to 8°C (36°F to 46°F). RIVFLOZA can be stored, if needed, at 15°C to 30°C (59°F to 86°F) for a maximum of 28 days (4 weeks). Do not freeze. Store in original carton, away from direct heat and light.</paragraph>
                        <list listType="ordered">
                           <item>
                              <caption> </caption>
                              <content styleCode="bold">Table 4: Storage Conditions for RIVFLOZA</content>
                           </item>
                        </list>
                        <table cellpadding="0pt" width="100%">
                           <col width="16%"/>
                           <col width="26%"/>
                           <col width="37%"/>
                           <tbody>
                              <tr>
                                 <td styleCode="Rrule Botrule Lrule Toprule " valign="top"/>
                                 <td align="justify" styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Refrigerated</paragraph>
                                    <paragraph>2°C to 8°C (36°F to 46°F)</paragraph>
                                 </td>
                                 <td styleCode="Rrule Botrule Toprule " valign="top">
                                    <paragraph>Room Temperature at 15°C to 30°C</paragraph>
                                    <paragraph>(59°F to 86°F)</paragraph>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="justify" styleCode="Rrule Botrule Lrule " valign="top">
                                    <paragraph>RIVFLOZA</paragraph>
                                 </td>
                                 <td align="justify" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Until expiration date</paragraph>
                                 </td>
                                 <td align="justify" styleCode="Rrule Botrule " valign="top">
                                    <paragraph>Maximum 28 days (4 weeks)</paragraph>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250303"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_964bec6a-03b2-461e-8bb0-e7c7d0dd065c">
               <id root="32ec232f-c4ff-4fd0-a3ba-90a32f15b2b6"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION </title>
               <text>
                  <list listType="ordered">
                     <item>
                        <caption> </caption>Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).</item>
                     <item>
                        <caption>•</caption>Instruct patients/caregivers on the appropriate dose of RIVFLOZA to use, the timing of the dose, how and where to inject subcutaneously, and what to do if a dose is missed.</item>
                  </list>
                  <paragraph>For more information contact:<br/>Dicerna Pharmaceuticals, Inc.<br/>A Novo Nordisk company</paragraph>
                  <paragraph>Novo Nordisk Inc.<br/>800 Scudders Mill Road<br/>Plainsboro, NJ 08536<br/>1-844-906-5099</paragraph>
                  <paragraph>Manufactured by<br/>Pyramid Laboratories<br/>3598 Cadillac Ave<br/>Costa Mesa, CA 92626</paragraph>
               </text>
               <effectiveTime value="20250303"/>
            </section>
         </component>
         <component>
            <section ID="ID_24943c0c-6c1a-4ec2-aee8-531c101fcd68">
               <id root="c07f7faa-1770-43ba-9ae8-0e217e4d280e"/>
               <code code="42230-3" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PATIENT PACKAGE INSERT SECTION"/>
               <title>Patient Package Insert </title>
               <text>
                  <table width="100%">
                     <col width="100%"/>
                     <tbody>
                        <tr>
                           <td align="center" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">PATIENT INFORMATION</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>® </sup>(Riv</content>-<content styleCode="bold">flo-za)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(nedosiran)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">injection, for subcutaneous use</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What is RIVFLOZA?</content>
                              </paragraph>
                              <paragraph>RIVFLOZA is a prescription medicine used to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.</paragraph>
                              <paragraph>It is not known if RIVFLOZA is safe and effective in children younger than 2 years of age.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Before using RIVFLOZA, tell your healthcare provider about all of your medical conditions, including if you:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>are pregnant or plan to become pregnant. It is not known if RIVFLOZA will harm your unborn baby.</item>
                                 <item>
                                    <caption>•</caption>are breastfeeding or plan to breastfeed. It is not known if RIVFLOZA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with RIVFLOZA.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Tell your healthcare provider about all the medicines you take,</content> including prescription and over-the-counter medicines, vitamins, and herbal supplements.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I use RIVFLOZA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Read the detailed Instructions for Use that comes with RIVFLOZA about the right way to prepare and inject RIVFLOZA.</content>
                                 </item>
                                 <item>
                                    <caption>•</caption>Use RIVFLOZA exactly as your healthcare provider tells you to.</item>
                                 <item>
                                    <caption>•</caption>Inject RIVFLOZA under your skin (subcutaneous injection).</item>
                                 <item>
                                    <caption>•</caption>Use RIVFLOZA 1 time each month.</item>
                                 <item>
                                    <caption>•</caption>Your healthcare provider will prescribe the dose of RIVFLOZA that is right for you or your child based on your or your child’s body weight.</item>
                                 <item>
                                    <caption>•</caption>RIVFLOZA comes as a single-dose Pre-filled Syringe and as a single-dose vial.</item>
                                 <item>
                                    <caption>•</caption>Your healthcare provider will show you or your caregiver how to prepare and inject RIVFLOZA. Do not try to inject RIVFLOZA until you or your caregiver have been shown the right way by your healthcare provider.</item>
                                 <item>
                                    <caption>•</caption>In children 2 years of age to less than 12 years of age weighing 86 pounds (39 kilograms) or more, it is recommended that RIVFLOZA Pre-filled Syringe be given by a healthcare provider or caregiver.</item>
                                 <item>
                                    <caption>•</caption>If you miss a dose of RIVFLOZA, inject the dose as soon as possible. If you miss a dose of RIVFLOZA by more than 7 days, inject the dose as soon as possible and resume monthly dosing from the most recently injected dose. If you have any questions about a missed dose, call your healthcare provider or pharmacist.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What are the possible side effects of RIVFLOZA?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">The most common side effects of RIVFLOZA include</content> injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.</paragraph>
                              <paragraph>These are not all the possible side effects of RIVFLOZA.</paragraph>
                              <paragraph>Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</paragraph>
                              <paragraph>You may also report side effects to Novo Nordisk at 1-844-906-5099.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I store RIVFLOZA?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Store RIVFLOZA in the refrigerator between 36°F to 46°F (2°C to 8°C).</item>
                                 <item>
                                    <caption>•</caption>If needed, RIVFLOZA can be stored between 59°F to 86°F (15°C to 30°C) for up to 28 days (4 weeks). Record the date RIVFLOZA was removed from the refrigerator on the carton and throw away (dispose of) if not used within 28 days.</item>
                                 <item>
                                    <caption>•</caption>Do not freeze RIVFLOZA.</item>
                                 <item>
                                    <caption>•</caption>Store RIVFLOZA in the original carton.</item>
                                 <item>
                                    <caption>•</caption>Keep RIVFLOZA away from direct heat and light.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Keep RIVFLOZA and all medicines out of the reach of children.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">General information about the safe and effective use of RIVFLOZA.</content>
                              </paragraph>
                              <paragraph>Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use RIVFLOZA for a condition for which it was not prescribed. Do not give RIVFLOZA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about RIVFLOZA that is written for health professionals.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What are the ingredients in RIVFLOZA?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Active ingredient:</content> nedosiran</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Inactive ingredients:</content> water for injection and sodium hydroxide and/or hydrochloric acid.</paragraph>
                              <paragraph>For more information contact: Dicerna Pharmaceuticals, Inc., A Novo Nordisk company</paragraph>
                              <paragraph>Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ 08536</paragraph>
                              <paragraph>1-844-906-5099</paragraph>
                              <paragraph>Manufactured by: Pyramid Laboratories, 3598 Cadillac Ave, Costa Mesa, CA 92626</paragraph>
                              <paragraph>For more information, go to https://www.rivfloza.com/ or call 1-844-906-5099.</paragraph>
                              <paragraph>This Patient Information has been approved by the U.S. Food and Drug Administration.            Revised: 03/2025</paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250303"/>
            </section>
         </component>
         <component>
            <section ID="ID_83c55922-7274-4df5-a3a2-66bf29285057">
               <id root="cb8ceecb-b284-4c57-a641-585c7cc37d80"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Instructions for Use – Pre-filled Syringe </title>
               <text>
                  <table width="100%">
                     <col width="50%"/>
                     <col width="0%"/>
                     <col width="0%"/>
                     <col width="50%"/>
                     <tbody>
                        <tr>
                           <td align="center" colspan="4" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>® </sup>(Riv-flo-za)<br/> (nedosiran)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">injection, for subcutaneous use</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Single-dose Pre-filled Syringe</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top"/>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>This Instructions for Use contains information on how to inject RIVFLOZA.</paragraph>
                              <paragraph>Read the Instructions for Use before using RIVFLOZA Pre-filled Syringe and each time you get a refill. There may be new information. Ask your or your child’s healthcare provider if you have any questions.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA Pre-filled Syringe Parts</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA Pre-filled Syringe is available in 2 dose strengths.</content> You should check the label on the carton that comes with the RIVFLOZA Pre-filled Syringe to make sure you have the right Pre-filled Syringe for the prescribed dose.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">For adults and children 12 years of age and older weighing less than 110 pounds (50 kilograms)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">and</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">For children 2 years of age to less than 12 years of age weighing between 86 pounds (39 kilograms) and less than 110 pounds (50 kilograms):</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>®</sup>
                                 </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(nedosiran) injection</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">For subcutaneous injection only</content>
                              </paragraph>
                           </td>
                           <td colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1084910420" referencedObject="C0EA68E8-5F74-4EC5-B56B-258774CA0373"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">For adults and children 2 years of age and older weighing 110 pounds (50 kilograms) or more:</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>®</sup>
                                 </content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(nedosiran) injection</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">For subcutaneous injection only</content>
                              </paragraph>
                           </td>
                           <td colspan="3" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-656996306" referencedObject="D9F9DBD7-86D0-45ED-8969-ACDDA050239B"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Important information you need to know before injecting RIVFLOZA.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Your or your child’s healthcare  provider will show you how to prepare and inject RIVFLOZA before you use the Pre-filled Syringe for the first time. </item>
                                 <item>
                                    <caption>•</caption>Use RIVFLOZA Pre-filled Syringe exactly as your or your child’s healthcare provider tells you to.</item>
                                 <item>
                                    <caption>•</caption>In children 2 years of age to less than 12 years of age it is recommended that RIVFLOZA Pre-filled Syringe be given by a healthcare provider or caregiver.</item>
                                 <item>
                                    <caption>•</caption>Your or your child’s healthcare provider will tell you when and how to inject RIVFLOZA.</item>
                                 <item>
                                    <caption>•</caption>RIVFLOZA Pre-filled Syringe is a single-dose Pre-filled Syringe for one-time (single) use only. <content styleCode="bold">Do not</content> reuse the Pre-filled Syringe.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> use the Pre-filled Syringe if the carton is damaged or if the tamper-proof seal is not intact.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> use if the expiration date on the carton has passed.</item>
                                 <item>
                                    <caption>•</caption>RIVFLOZA Pre-filled Syringe is for injection under the skin (subcutaneous injection) only. <content styleCode="bold">Do not</content> inject RIVFLOZA into a vein.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Supplies needed to give the injection:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>1 RIVFLOZA Pre-filled Syringe</item>
                                 <item>
                                    <caption> </caption>The following supplies are not included in the carton:</item>
                                 <item>
                                    <caption>•</caption>Alcohol wipe</item>
                                 <item>
                                    <caption>•</caption>Cotton balls or gauze</item>
                                 <item>
                                    <caption>•</caption>Puncture resistant sharps disposal container. See Step 12 <content styleCode="bold">“Throw away (dispose of) the used RIVFLOZA Pre-filled Syringe”</content> at the end of this Instructions for Use<content styleCode="bold">.</content>
                                 </item>
                              </list>
                           </td>
                           <td colspan="2" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1644888926" referencedObject="dc2d99d0-60ca-4bbc-aff9-f0209c9ce5dc"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I store RIVFLOZA Pre-filled Syringe?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Store unused RIVFLOZA Pre-filled Syringes in the refrigerator between 36°F to 46°F (2°C to 8°C).</item>
                                 <item>
                                    <caption>•</caption>If needed, RIVFLOZA Pre-filled Syringes can be stored between 59°F to 86°F (15°C to 30°C) for no longer than 28 days (4 weeks). Record the date RIVFLOZA was removed from the refrigerator on the carton and throw away (dispose of) if not used within 28 days. </item>
                                 <item>
                                    <caption>•</caption>Store RIVFLOZA Pre-filled Syringes in the original carton.</item>
                                 <item>
                                    <caption>•</caption>Keep RIVFLOZA Pre-filled Syringes away from direct heat and light. </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> freeze. </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Keep RIVFLOZA Pre-filled Syringe and all medicines out of the reach of children.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id364097454" referencedObject="C83C7AE3-B407-466D-8172-E2DCBAFC9174"/>
                              <renderMultiMedia ID="id-91246938" referencedObject="ID_8b58457d-22e1-412d-8f12-ab703f974370"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">A. Preparing for the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 1. Gather the supplies and place the supplies on a clean, flat surface in a well-lit area.</content>
                              </paragraph>
                           </td>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1795173927" referencedObject="AD7329E0-6B13-4778-B7CE-B5C231923322"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 2. Remove the RIVFLOZA Pre-filled Syringe carton from the refrigerator.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Make sure the carton contains the correct dose. </item>
                                 <item>
                                    <caption>•</caption>Check the expiration date on the carton. <content styleCode="bold">Do not</content> use if the expiration date has passed. </item>
                                 <item>
                                    <caption>•</caption>Wait 30 minutes before injecting to allow the medicine in the Pre-filled Syringe to warm to room temperature.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Keep the RIVFLOZA Pre-filled Syringe in the carton and out of direct heat and sunlight.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> warm the Pre-filled Syringe using any heat sources such as hot water or a microwave.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1721972934" referencedObject="ID_69dc5e9f-2f17-476d-9a20-997be9a0ab4f"/>
                              <renderMultiMedia ID="id24831198" referencedObject="A84D1EE4-883E-44AA-B0A2-4698B2C49B50"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 3. Wash your hands with soap and water.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 4. Open the carton and remove the RIVFLOZA Pre-filled Syringe.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Grip the barrel of the Pre-filled Syringe and remove it from the carton.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1752857270" referencedObject="E07C0B06-DE76-4BDE-89F1-F0093188CCE0"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 5. Inspect the RIVFLOZA Pre-filled Syringe.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Look at the medicine in the Pre-filled Syringe. The medicine should be colorless to yellow and free of particles. </item>
                                 <item>
                                    <caption>o</caption>
                                    <content styleCode="bold">Do not</content> use the Pre-filled Syringe if the medicine looks cloudy, discolored, or contains particles.</item>
                                 <item>
                                    <caption>•</caption>The Pre-filled Syringe should not look damaged.<list listType="unordered">
                                       <item>
                                          <caption>o</caption>
                                          <content styleCode="bold">Do not</content> use the Pre-filled Syringe if it looks damaged.</item>
                                    </list>
                                 </item>
                              </list>
                              <paragraph>You may see small air bubbles in the liquid. This is normal.</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1990597060" referencedObject="ID_3c62cbbc-9e12-420f-a994-3ddcf7e4785f"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 6. Choose the injection site.</content>
                              </paragraph>
                              <paragraph>You may inject into skin of:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>the stomach area (abdomen) at least 2 inches from the belly button, <content styleCode="bold">or</content>
                                 </item>
                                 <item>
                                    <caption>•</caption>the upper thigh.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> inject into scarred or bruised skin.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1071586980" referencedObject="ID_4986d606-d404-4073-8675-9f7baba84ca1"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 7. Clean the injection site. </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Clean the injection site with an alcohol wipe and let it air dry. </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> touch, wipe with other material, fan, or blow on the cleaned injection site.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-74980235" referencedObject="ID_678c99b9-3a95-4526-82c5-deb05972be2a"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">B. Giving the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 8. Remove the needle cap and throw it away in the sharps disposal container.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Hold the Pre-filled Syringe with 1 hand and the needle pointed away from you. Pull the needle cap straight off with your other hand as shown.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>If the needle appears to be bent or damaged, <content styleCode="bold">do not</content> use the Pre-filled Syringe.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> touch or recap the needle.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> touch the plunger rod until you are ready to inject.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-983461140" referencedObject="ID_977d6995-4889-4b1c-921d-9b8ec359f20a"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 9. Pinch the skin and fully insert the needle.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Pinch the skin around the clean injection site with 1 hand.</item>
                                 <item>
                                    <caption>•</caption>Grasp the finger grip of the Pre-filled Syringe with your other hand and fully insert the needle into the injection site at a 45-degree angle.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1168400631" referencedObject="ID_3eb28165-2dcb-488f-8b04-6eb49855fe06"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 10. Slowly inject all the medicine. </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Gently push the plunger rod all the way down until the Pre-filled Syringe is empty.</item>
                                 <item>
                                    <caption>•</caption>You will see the rubber stopper inside the Pre-filled Syringe move to the bottom of the barrel as the medicine is injected.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1800262719" referencedObject="ID_359612b4-b9d8-4784-bbed-895e0e40bab1"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 11. Remove the RIVFLOZA Pre-filled Syringe from the injection site.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> recap the needle.</item>
                              </list>
                              <paragraph>If there is bleeding, lightly press a cotton ball or gauze over the injection site.</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-601719243" referencedObject="ID_56d741b2-bb45-4ae7-8f2e-24abfd1f3cb7"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">C. After the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 12. Throw away (dispose of) the used RIVFLOZA Pre-filled Syringe.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Put the used RIVFLOZA Pre-filled Syringe in an FDA-cleared sharps disposal container right away after use.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> throw away (dispose of) RIVFLOZA Pre-filled Syringes and needle caps in your household trash.</item>
                                 <item>
                                    <caption>•</caption>If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:</item>
                                 <item>
                                    <caption>o</caption>made of a heavy-duty plastic,</item>
                                 <item>
                                    <caption>o</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out, </item>
                                 <item>
                                    <caption>o</caption>upright and stable during use, </item>
                                 <item>
                                    <caption>o</caption>leak-resistant, and </item>
                                 <item>
                                    <caption>o</caption>properly labeled to warn of hazardous waste inside the container. </item>
                                 <item>
                                    <caption>•</caption>When the sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. </item>
                                 <item>
                                    <caption>•</caption>For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal. </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> dispose of the used sharps disposal container in your household trash unless your community guidelines permit this. </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> recycle the used sharps disposal container.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id125053314" referencedObject="FB8B6E83-4F2D-46BC-8703-EEA815612B39"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Flip Page for more Information  </content>
                                 <content styleCode="bold">
                                    <renderMultiMedia ID="id1515727257" referencedObject="ID_65896afb-406c-45c6-85b9-490022817736"/>
                                 </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Frequently asked questions</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if a dose is missed?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>If a dose of RIVFLOZA is missed, inject the dose as soon as possible.</item>
                                 <item>
                                    <caption>•</caption>If a dose of RIVFLOZA is missed by more than 7 days, inject the dose as soon as possible and resume monthly dosing from the most recently injected dose.</item>
                              </list>
                              <paragraph>If you have any questions about a missed dose, call your healthcare provider or pharmacist.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if I damage or break the RIVFLOZA Pre-filled Syringe?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Do not use a broken or damaged Pre-filled Syringe. Call the pharmacy for a replacement.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Do I inject the full volume of the Pre-filled Syringe?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Yes, the Pre-filled Syringe is for one-time (single) use and contains 1 complete dose.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">“Pull Out” panel (on front of IFU)</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <content styleCode="bold">
                                 <renderMultiMedia ID="id1599667019" referencedObject="ID_654049fb-a23b-4dd5-a867-93f82e93cfb4"/>
                              </content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <renderMultiMedia ID="id-292132288" referencedObject="ID_32be0903-553b-4c31-bca1-4ab00c4ae198"/>  Read Entire Instructions Before Use</paragraph>
                              <paragraph>
                                 <renderMultiMedia ID="id1958447233" referencedObject="ID_8ccde8b7-7b70-4efb-a860-8a43b2d6c0b8"/>  Follow Instructions Carefully</paragraph>
                              <paragraph>
                                 <renderMultiMedia ID="id-337779360" referencedObject="ID_210d96a2-4bcc-45bd-88ae-2ef2d474e634"/>  Contact Novo Nordisk for any Questions</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="3" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>®</sup>
                                 </content> (Riv-flo-za) </paragraph>
                              <paragraph>(nedosiran) injection,</paragraph>
                              <paragraph>for subcutaneous use</paragraph>
                              <paragraph>Single-dose Pre-filled Syringe</paragraph>
                           </td>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id328183961" referencedObject="ID_7cb77da1-4900-421f-a198-fd695a4500a9"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Address Panel</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>For more information go to <content styleCode="underline">https://www.rivfloza.com/</content> or call <content styleCode="bold">1-844-906-5099.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Dicerna Pharmaceuticals, Inc.</content>
                              </paragraph>
                              <paragraph>A Novo Nordisk company</paragraph>
                              <paragraph>Novo Nordisk Inc.</paragraph>
                              <paragraph>800 Scudders Mill Road</paragraph>
                              <paragraph>Plainsboro, NJ 08536 USA</paragraph>
                              <paragraph>1-888-906-5099</paragraph>
                              <paragraph>Manufactured by:</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Pyramid Laboratories</content>
                              </paragraph>
                              <paragraph>3598 Cadillac Avenue</paragraph>
                              <paragraph>Costa Mesa, CA 92626 USA</paragraph>
                              <paragraph>Version: 3</paragraph>
                              <paragraph>© 2025 Novo Nordisk</paragraph>
                              <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.</paragraph>
                              <paragraph>Revised: 03/2025</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="4" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Flip Page for Instructions for Use</content>
                                 <content styleCode="bold">
                                    <renderMultiMedia ID="id965850845" referencedObject="ID_784d308b-497b-42da-b2b3-48e21d2fef01"/>
                                 </content>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="C0EA68E8-5F74-4EC5-B56B-258774CA0373">
                     <text>image_03</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="D9F9DBD7-86D0-45ED-8969-ACDDA050239B">
                     <text>image_04</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="dc2d99d0-60ca-4bbc-aff9-f0209c9ce5dc">
                     <text>image-5</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="C83C7AE3-B407-466D-8172-E2DCBAFC9174">
                     <text>image_06</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8b58457d-22e1-412d-8f12-ab703f974370">
                     <text>image_07</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-06.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AD7329E0-6B13-4778-B7CE-B5C231923322">
                     <text>image_08</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-07.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_69dc5e9f-2f17-476d-9a20-997be9a0ab4f">
                     <text>image_09</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-08.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A84D1EE4-883E-44AA-B0A2-4698B2C49B50">
                     <text>image_10</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-09.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="E07C0B06-DE76-4BDE-89F1-F0093188CCE0">
                     <text>image_11</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-10.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3c62cbbc-9e12-420f-a994-3ddcf7e4785f">
                     <text>image_12</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-11.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_4986d606-d404-4073-8675-9f7baba84ca1">
                     <text>image_13</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-12.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_678c99b9-3a95-4526-82c5-deb05972be2a">
                     <text>image_14</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-13.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_977d6995-4889-4b1c-921d-9b8ec359f20a">
                     <text>image_15</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-14.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3eb28165-2dcb-488f-8b04-6eb49855fe06">
                     <text>image_16</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-15.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_359612b4-b9d8-4784-bbed-895e0e40bab1">
                     <text>image_17</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-16.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_56d741b2-bb45-4ae7-8f2e-24abfd1f3cb7">
                     <text>image_18</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-17.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="FB8B6E83-4F2D-46BC-8703-EEA815612B39">
                     <text>image_19</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-18.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_65896afb-406c-45c6-85b9-490022817736">
                     <text>flip-arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="flip-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_654049fb-a23b-4dd5-a867-93f82e93cfb4">
                     <text>pull-out-arrow</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="pull-out-arrow.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_32be0903-553b-4c31-bca1-4ab00c4ae198">
                     <text>image_20</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-19.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8ccde8b7-7b70-4efb-a860-8a43b2d6c0b8">
                     <text>image_21</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-20.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_210d96a2-4bcc-45bd-88ae-2ef2d474e634">
                     <text>image_22</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-21.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_7cb77da1-4900-421f-a198-fd695a4500a9">
                     <text>128-160-2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="128-160-2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_784d308b-497b-42da-b2b3-48e21d2fef01">
                     <text>flip-arrow-1</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="flip-arrow-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_b9191794-531b-4208-91d9-37fe741bc148">
               <id root="0da70328-61ae-49da-8024-022a45df4fde"/>
               <code code="59845-8" codeSystem="2.16.840.1.113883.6.1" displayName="INSTRUCTIONS FOR USE SECTION"/>
               <title>Instructions for Use - Vial </title>
               <text>
                  <table width="100%">
                     <col width="50%"/>
                     <col width="50%"/>
                     <tbody>
                        <tr>
                           <td align="center" colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>®</sup> (Riv-flo-za)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">(nedosiran)</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">injection, for subcutaneous use</content>
                              </paragraph>
                              <paragraph>Single-dose vial</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>This Instructions for Use contains information on how to inject RIVFLOZA using the single-dose vial in:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>children 2 years of age to less than 12 years of age weighing less than 86 pounds (39 kilograms).</item>
                                 <item>
                                    <caption>•</caption>adults and children using the single-dose vial as an alternative to the single-dose Pre-filled syringe.</item>
                              </list>
                              <paragraph>Read the Instructions for Use before using RIVFLOZA vial and each time you get a refill. There may be new information. Ask your or your child’s healthcare provider if you have any questions.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td align="center" colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <renderMultiMedia ID="id-2094691236" referencedObject="ID_14bcc91f-f8f0-497c-8edd-0014aff45665"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Important information you need to know before injecting RIVFLOZA.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Your or your child’s healthcare provider will show you how to prepare and inject RIVFLOZA. <content styleCode="bold">Do not</content> try to inject RIVFLOZA until you have been shown the right way by your or your child’s healthcare provider.</item>
                                 <item>
                                    <caption>•</caption>Use RIVFLOZA vials exactly as your or your child’s healthcare provider tells you to.</item>
                                 <item>
                                    <caption>•</caption>Your or your child’s healthcare provider will tell you how much RIVFLOZA to inject and when to inject it.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> use the RIVFLOZA vial if the carton is damaged or if the tamper-proof seal is not intact. </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> use the RIVFLOZA vial if the expiration date on the carton has passed.</item>
                                 <item>
                                    <caption>•</caption>Uncap the RIVFLOZA vial only when ready to give an injection. Under the vial cap, you will see a grey rubber stopper. <content styleCode="bold">Do not</content> remove it. It is supposed to be there.</item>
                                 <item>
                                    <caption>•</caption>RIVFLOZA vials are for one-time use (single-dose) only. <content styleCode="bold">Do not </content>reuse the RIVFLOZA vial. Throw away (discard of) any unused RIVFLOZA.</item>
                                 <item>
                                    <caption>•</caption>RIVFLOZA is for injection under the skin (subcutaneous injection) only. <content styleCode="bold">Do not</content> inject RIVFLOZA into a vein.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Supplies needed to give the injection</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If the amount of RIVFLOZA needed for your or your child’s prescribed dose is 0.5 mL or less, you will need the following supplies:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>1 RIVFLOZA vial</item>
                              </list>
                              <paragraph>The following supplies are not included in the carton: </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>One 1 mL syringe with attached 27-gauge 1/2” needle</item>
                                 <item>
                                    <caption>•</caption>Alcohol wipes</item>
                                 <item>
                                    <caption>•</caption>Cotton balls or gauze</item>
                                 <item>
                                    <caption>•</caption>Puncture resistant sharps disposal container. See Step 16 “<content styleCode="bold">Throw away (dispose of) the used syringe(s)” </content>at the end of this Instructions for Use. </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">If the amount of RIVFLOZA needed for your or your child’s prescribed dose is 0.6 mL or more, you will need the following supplies:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>2 RIVFLOZA vials</item>
                              </list>
                              <paragraph>The following supplies are not included in the carton:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Two 1 mL syringes with attached 27-gauge 1/2” needle</item>
                                 <item>
                                    <caption>•</caption>Alcohol wipes</item>
                                 <item>
                                    <caption>•</caption>Cotton balls or gauze</item>
                                 <item>
                                    <caption>•</caption>Puncture resistant sharps disposal container. See Step 16 “<content styleCode="bold">Throw away (dispose of) the used syringe(s)” </content>at the end of this Instructions for Use.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1506193975" referencedObject="F4456421-7A22-4343-A797-DFB1FE7CCFE1"/>
                              <renderMultiMedia ID="id1954660923" referencedObject="F7AC7313-B384-4B06-BE98-E9FAEB7F1D3C"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">How should I store RIVFLOZA vials?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Store RIVFLOZA vials in the refrigerator between 36°F to 46°F (2°C to 8°C).</item>
                                 <item>
                                    <caption>•</caption>If needed, RIVFLOZA vials may be stored between 59°F to 86°F (15°C to 30°C) for no longer than 28 days (4 weeks). Record the date RIVFLOZA was removed from the refrigerator on the carton and throw away (dispose of) if not used within 28 days.</item>
                                 <item>
                                    <caption>•</caption>Store RIVFLOZA in the original carton.</item>
                                 <item>
                                    <caption>•</caption>Keep RIVFLOZA vials away from direct heat and light.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> freeze.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Keep RIVFLOZA vials and all medicines out of the reach of children.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">A. Preparing for the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 1. Gather the supplies and place the supplies on a clean, flat surface in a well-lit area.</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1069340345" referencedObject="ID_5b7231ad-922e-4550-ba59-4e91b112a131"/>
                              <renderMultiMedia ID="id-619613204" referencedObject="ID_9b6dd6ca-f1ca-4de0-b8a8-89f785aec691"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 2. Remove the RIVFLOZA vial carton(s) from the refrigerator.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Check the expiration date on the carton. <content styleCode="bold">Do not</content> use if the expiration date on the carton has passed.</item>
                                 <item>
                                    <caption>•</caption>Wait 30 minutes before injecting to allow the medicine in the vial to warm to room temperature.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Keep the RIVFLOZA vial in the carton and out of direct heat and sunlight.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> warm the vial using any heat sources such as hot water or a microwave.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id1870786302" referencedObject="AA78AAC7-2EDF-4074-9501-7DCF60DE57E8"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 3. Wash your hands with soap and water.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 4. Open the carton(s) and remove the RIVFLOZA vial(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Check the vial label to make sure you have the correct medicine for the prescription.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-350493593" referencedObject="ID_819e2ace-ed06-44ce-9ac0-c6d2ec1aae07"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 5. Inspect the RIVFLOZA vial(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Look at the medicine in the vial. It should be colorless to yellow and free of particles.<list listType="unordered">
                                       <item>
                                          <caption>o</caption>
                                          <content styleCode="bold">Do not </content>use the vial if the medicine looks cloudy, discolored, or contains particles.</item>
                                    </list>
                                 </item>
                                 <item>
                                    <caption>•</caption>The vial should not look damaged.<list listType="unordered">
                                       <item>
                                          <caption>o</caption>
                                          <content styleCode="bold">Do not</content> use the vial if the vial looks damaged.</item>
                                    </list>
                                 </item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1221586752" referencedObject="ID_73756593-dd47-430d-8c36-867294112c0e"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 6. Choose the injection site(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>You may inject into the skin of:<list listType="unordered">
                                       <item>
                                          <caption>o</caption>the stomach area (abdomen) at least 2 inches from the belly button, <content styleCode="bold">or</content>
                                       </item>
                                       <item>
                                          <caption>o</caption>the upper thigh.</item>
                                    </list>
                                 </item>
                                 <item>
                                    <caption>•</caption>If the dose is more than 0.5 mL (2 injections), inject the contents of each syringe in a different location. If both injections are in the abdomen, they should be in different areas of the abdomen.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> inject into scarred or bruised skin.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not </content>inject the contents of 2 syringes into the same location.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id-643808797" referencedObject="AB1217FB-BA70-4F5C-BF38-8CA8DE6BA0D0"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 7. Clean the injection site(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Clean the injection site(s) with an alcohol wipe and let it air dry.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> touch, wipe with other material, fan, or blow on the cleaned injection site(s).</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-429278019" referencedObject="ID_91629d61-3dcf-461c-93d8-88b5e6ae1831"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 8. Prepare the vial(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Remove the cap from the vial(s) you will need.</item>
                                 <item>
                                    <caption>•</caption>Clean the top of the grey rubber stopper with a <content styleCode="bold">new</content> alcohol wipe.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> remove the grey rubber stopper from the vial. It is supposed to be there.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id382686658" referencedObject="F7F65582-887F-41AD-BE3F-5722E0EC5A1B"/>
                              <renderMultiMedia ID="id-210896726" referencedObject="ID_5a54bb29-3316-483f-991a-c530cedaa4a2"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">B. Giving the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 9. Remove the syringe with attached needle from the packaging and remove the needle cap. Throw the needle cap away in the sharps disposal container.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Remove the needle cap by pulling it straight off and away from your body. </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Take care when handling the uncapped needle.</content>
                                 </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not touch the uncapped needle.</content>
                                 </item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1223033684" referencedObject="ID_34a32ee6-37f6-46f3-a812-fee2509ebd48"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 10. Withdraw RIVFLOZA into the syringe.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">If the dose amount is 0.5 mL or less:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Insert the needle into the grey rubber stopper on top of the vial.</item>
                                 <item>
                                    <caption>•</caption>Turn the vial and syringe upside down.</item>
                                 <item>
                                    <caption>•</caption>Keep the tip of the needle in the medicine.</item>
                                 <item>
                                    <caption>•</caption>Hold the syringe and vial in 1 hand. With your other hand, slowly pull back on the plunger rod to withdraw the prescribed dose into the syringe.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">If the dose amount is 0.6 mL or more:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>You will need to withdraw the dose of RIVFLOZA from 2 vials using 2 separate syringes.</item>
                                 <item>
                                    <caption>•</caption>Follow <content styleCode="bold">“If the dose amount is 0.5 mL or less” </content>instructions to withdraw the amount of medicine needed from each vial as instructed by your or your child’s healthcare provider. Then follow <content styleCode="bold">Steps 11 to 16</content> for each syringe to inject RIVFLOZA.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-64036448" referencedObject="ID_09735d22-1562-43fb-8fb0-23f3a6a982b1"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 11. Remove any large air bubbles from the syringe.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>If you see large air bubbles in the syringe, tap the side of the syringe to move any air bubbles to the top of the syringe.</item>
                                 <item>
                                    <caption>•</caption>Push the plunger rod up to push the air bubbles back into the vial.</item>
                                 <item>
                                    <caption>•</caption>If the syringe does not contain the correct dose after the large air bubbles are removed, you will need to pull back on the plunger rod again to fill the syringe with the prescribed dose.</item>
                                 <item>
                                    <caption>•</caption>Look at the syringe to make sure you have the correct amount for the dose.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Be sure the syringe is free of large air bubbles before you inject.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id663975457" referencedObject="F6129A45-3073-4E29-BEE1-736121018618"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 12. Turn the vial and syringe back upright and remove the needle from the vial.</content>
                              </paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id1016811428" referencedObject="A5C53747-C2A1-4431-B397-830E32B05E0B"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 13. Pinch the skin and fully insert the needle.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Pinch the skin around the injection site with 1 hand.</item>
                                 <item>
                                    <caption>•</caption>With your other hand, fully insert the needle into the skin at a 45-degree angle.</item>
                                 <item>
                                    <caption>•</caption>If you are giving 2 injections, inject each syringe in a different location. If both injections are in the abdomen, they should be in different areas of the abdomen.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1804232476" referencedObject="BDFCA0A9-33B1-4E14-A164-658662FCE038"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 14. Slowly inject all the medicine.</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Gently push the plunger rod all the way down until the syringe is empty.</item>
                                 <item>
                                    <caption>•</caption>You will see the rubber stopper inside the syringe move to the bottom of the barrel as the medicine is injected.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-1188910900" referencedObject="EEF1E57E-0DE8-4021-AB0C-020877DD3188"/>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 15. Remove the needle from the injection site.</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Caution:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> recap the needle.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not </content>save or keep used syringes.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Throw away (dispose of) the used vial(s) in household trash.</content>
                              </paragraph>
                              <paragraph>If there is bleeding, lightly press a cotton ball or gauze over the injection site.</paragraph>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id-357590841" referencedObject="ID_38e65179-6e53-47e9-891b-cce8e4a3e990"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">C. After the injection</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Step 16. Throw away (dispose of) the used syringe(s).</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Put the used syringe(s) with the needle still attached in an FDA-cleared sharps container right away after use.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> throw away (dispose of) needles and syringes in your household trash.</item>
                                 <item>
                                    <caption>•</caption>If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:</item>
                                 <item>
                                    <caption>o</caption>made of a heavy-duty plastic,</item>
                                 <item>
                                    <caption>o</caption>can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,</item>
                                 <item>
                                    <caption>o</caption>upright and stable during use,</item>
                                 <item>
                                    <caption>o</caption>leak-resistant, and</item>
                                 <item>
                                    <caption>o</caption>properly labeled to warn of hazardous waste inside the container.</item>
                                 <item>
                                    <caption>•</caption>When the sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes.</item>
                                 <item>
                                    <caption>•</caption>For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: <content styleCode="underline">http://www.fda.gov/safesharpsdisposal</content>
                                 </item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> dispose of the used sharps disposal container in your household trash unless your community guidelines permit this.</item>
                                 <item>
                                    <caption>•</caption>
                                    <content styleCode="bold">Do not</content> recycle the used sharps disposal container.</item>
                              </list>
                           </td>
                           <td align="center" styleCode="Rrule Lrule Toprule Botrule " valign="middle">
                              <renderMultiMedia ID="id1817994042" referencedObject="E6BED659-9E92-403C-8337-50F251F3FF5A"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Flip Page for More Information  </content>
                                 <content styleCode="bold">
                                    <renderMultiMedia ID="id118044756" referencedObject="ID_8812396b-9c55-44ad-a7a1-76e31546fc9f"/>
                                 </content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Frequently asked questions</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if a dose is missed? </content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>If a dose of RIVFLOZA is missed, inject the dose as soon as possible.</item>
                                 <item>
                                    <caption>•</caption>If a dose of RIVFLOZA is missed by more than 7 days, inject the RIVFLOZA dose as soon as possible and resume monthly dosing from the most recently injected dose.</item>
                              </list>
                              <paragraph>If you have any questions about a missed dose, call your healthcare provider or pharmacist.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if I damage or break the RIVFLOZA vial?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Do not use a broken or damaged vial. Call the pharmacy for a replacement.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Do I inject the full volume of the vial?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>The amount of RIVFLOZA you will inject depends on the prescribed dose. You may need more than one vial, one vial, or less than one vial for the prescribed dose.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">What if I need 2 vials for injection?</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <caption>•</caption>Use 2 separate syringes and withdraw the amount from each vial as directed by your or your child’s healthcare provider. Give 2 separate injections in a different location. If both injections are in the abdomen, they should be in different areas of the abdomen.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">“Pull Out” panel (on front of IFU)</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <content styleCode="bold">
                                 <renderMultiMedia ID="id-1419473375" referencedObject="AE3A919A-F59D-4999-A311-D61CB0D077FF"/>
                              </content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">INSTRUCTIONS FOR USE</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <renderMultiMedia ID="id309130111" referencedObject="F2F900B4-1062-4894-92CE-D34F11CDE5C0"/>Read Entire Instructions Before Use</paragraph>
                              <paragraph>
                                 <renderMultiMedia ID="id-1013761452" referencedObject="FADE2F3A-BB89-46E9-92F9-09B9CE028FF1"/>Follow Instructions Carefully</paragraph>
                              <paragraph>
                                 <renderMultiMedia ID="id142244542" referencedObject="ID_692de5f2-6e3b-4233-8db5-bbda7954d186"/>Contact Novo Nordisk for any Questions</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">RIVFLOZA<sup>®</sup>
                                 </content> (Riv-flo-za) </paragraph>
                              <paragraph>(nedosiran)</paragraph>
                              <paragraph>injection, for subcutaneous use </paragraph>
                              <paragraph>Single-dose vial</paragraph>
                           </td>
                           <td styleCode="Rrule Lrule Toprule Botrule " valign="top">
                              <renderMultiMedia ID="id1531142171" referencedObject="ID_1069086f-5c1e-4b76-839f-848da3557ad9"/>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Address Panel</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>For more information go to https://<linkHtml href="http://www.rivfloza.com">www.rivfloza.com</linkHtml>/ or call <content styleCode="bold">1-844-906-5099.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Lrule Botrule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Dicerna Pharmaceuticals, Inc.</content>
                              </paragraph>
                              <paragraph>A Novo Nordisk company</paragraph>
                              <paragraph>Novo Nordisk Inc.</paragraph>
                              <paragraph>800 Scudders Mill Road</paragraph>
                              <paragraph>Plainsboro, NJ 08536 USA</paragraph>
                              <paragraph>1-888-906-5099</paragraph>
                              <paragraph>Manufactured by:</paragraph>
                              <paragraph>
                                 <content styleCode="bold">Pyramid Laboratories</content>
                              </paragraph>
                              <paragraph>3598 Cadillac Avenue</paragraph>
                              <paragraph>Costa Mesa, CA 92626 USA</paragraph>
                              <paragraph>Version: 3</paragraph>
                              <paragraph>© 2025 Novo Nordisk</paragraph>
                              <paragraph>This Instructions for Use has been approved by the U.S. Food and Drug Administration.</paragraph>
                              <paragraph>Revised: 03/2025</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2" styleCode="Rrule Botrule Lrule Toprule " valign="top">
                              <paragraph>
                                 <content styleCode="bold">Flip Page for Instructions for Use   </content>
                                 <content styleCode="bold">
                                    <renderMultiMedia ID="id486828725" referencedObject="ID_3e6924bf-0bfe-49c1-a942-e44862763a80"/>
                                 </content>
                              </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="ID_14bcc91f-f8f0-497c-8edd-0014aff45665">
                     <text>80-mg-vial</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="80-mg-vial.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F4456421-7A22-4343-A797-DFB1FE7CCFE1">
                     <text>image_25</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-24.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F7AC7313-B384-4B06-BE98-E9FAEB7F1D3C">
                     <text>image_26</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-25.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5b7231ad-922e-4550-ba59-4e91b112a131">
                     <text>image_27</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-26.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_9b6dd6ca-f1ca-4de0-b8a8-89f785aec691">
                     <text>image_28</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-27.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AA78AAC7-2EDF-4074-9501-7DCF60DE57E8">
                     <text>image_29</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-28.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_819e2ace-ed06-44ce-9ac0-c6d2ec1aae07">
                     <text>image_30</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-29.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_73756593-dd47-430d-8c36-867294112c0e">
                     <text>image_31</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-30.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AB1217FB-BA70-4F5C-BF38-8CA8DE6BA0D0">
                     <text>image_32</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-31.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_91629d61-3dcf-461c-93d8-88b5e6ae1831">
                     <text>image_33</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-32.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F7F65582-887F-41AD-BE3F-5722E0EC5A1B">
                     <text>image_34</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-33.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_5a54bb29-3316-483f-991a-c530cedaa4a2">
                     <text>image_35</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_34a32ee6-37f6-46f3-a812-fee2509ebd48">
                     <text>image_36</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-34.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_09735d22-1562-43fb-8fb0-23f3a6a982b1">
                     <text>image_37</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-35.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F6129A45-3073-4E29-BEE1-736121018618">
                     <text>image_38</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-36.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="A5C53747-C2A1-4431-B397-830E32B05E0B">
                     <text>image_39</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-37.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="BDFCA0A9-33B1-4E14-A164-658662FCE038">
                     <text>image_40</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-38.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="EEF1E57E-0DE8-4021-AB0C-020877DD3188">
                     <text>image_41</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-39.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_38e65179-6e53-47e9-891b-cce8e4a3e990">
                     <text>image_42</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-40.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="E6BED659-9E92-403C-8337-50F251F3FF5A">
                     <text>image_43</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-41.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_8812396b-9c55-44ad-a7a1-76e31546fc9f">
                     <text>flip-arrow-2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="flip-arrow-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="AE3A919A-F59D-4999-A311-D61CB0D077FF">
                     <text>pull-out-arrow-2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="pull-out-arrow-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="F2F900B4-1062-4894-92CE-D34F11CDE5C0">
                     <text>image_44</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-42.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="FADE2F3A-BB89-46E9-92F9-09B9CE028FF1">
                     <text>image_45</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-43.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_692de5f2-6e3b-4233-8db5-bbda7954d186">
                     <text>image_46</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="image-44.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_1069086f-5c1e-4b76-839f-848da3557ad9">
                     <text>80-mg-vial-2</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="80-mg-vial-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="ID_3e6924bf-0bfe-49c1-a942-e44862763a80">
                     <text>flip-arrow-3</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="flip-arrow-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_cd84436f-eb9c-4920-8b2c-c81f6980984b">
               <id root="00d76d6e-ecd6-40d9-8c78-38c5fa541987"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – Pre-filled Syringe 128 mg/0.8 mL </title>
               <text>
                  <paragraph>NDC: 0169-5307-08</paragraph>
                  <paragraph>List 530708</paragraph>
                  <paragraph>rivfloza<sup>™</sup>
                  </paragraph>
                  <paragraph>(nedosiran) injection</paragraph>
                  <paragraph>128 mg/0.8 mL</paragraph>
                  <paragraph>
                     <content styleCode="bold">For subcutaneous injection only</content>
                  </paragraph>
                  <paragraph>1 x 0.8 mL Sterile Single-dose Pre-filled Syringe</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not</content> use the Pre-filled Syringe if the carton is damaged or if the tamper proof seal is not intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dicerna</content>
                     <sup>™</sup>
                  </paragraph>
                  <paragraph>a Novo Nordisk company</paragraph>
                  <renderMultiMedia ID="id-919409431" referencedObject="ID_3096ca93-87a5-4854-9666-35218431c6d2"/>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="ID_3096ca93-87a5-4854-9666-35218431c6d2">
                     <text>sleeve_128mg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="sleeve_128mg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_721dffba-1909-45cd-bee1-dac57281e9a4">
               <id root="b8449fc3-338d-4346-93c8-89e1a4ee924c"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – Pre-filled Syringe 160 mg/mL </title>
               <text>
                  <paragraph>NDC: 0169-5306-10</paragraph>
                  <paragraph>List 530610</paragraph>
                  <paragraph>rivfloza<sup>™</sup>
                  </paragraph>
                  <paragraph>(nedosiran) injection</paragraph>
                  <paragraph>160 mg/mL</paragraph>
                  <paragraph>
                     <content styleCode="bold">For subcutaneous injection only</content>
                  </paragraph>
                  <paragraph>1 x 1 mL Sterile Single-dose Pre-filled Syringe</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not</content> use the Pre-filled Syringe if the carton is damaged or if the tamper proof seal is not intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dicerna</content>
                     <sup>™</sup>
                  </paragraph>
                  <paragraph>a Novo Nordisk company</paragraph>
                  <renderMultiMedia ID="id422929295" referencedObject="ID_3c4a93d0-897e-405c-8316-ad1cad0ec742"/>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="ID_3c4a93d0-897e-405c-8316-ad1cad0ec742">
                     <text>sleeve_160mg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="sleeve_160mg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_3c4a20b9-c6c3-46b6-a0eb-7a7a85118792">
               <id root="45f44e26-c912-404b-a4aa-db01a93baf02"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL – Vial 80 mg/0.5 mL </title>
               <text>
                  <paragraph>NDC: 0169-5308-01</paragraph>
                  <paragraph>List 530801</paragraph>
                  <paragraph>rivfloza<sup>™</sup>
                  </paragraph>
                  <paragraph>(nedosiran) injection</paragraph>
                  <paragraph>80 mg/0.5 mL</paragraph>
                  <paragraph>
                     <content styleCode="bold">For subcutaneous injection only</content>
                  </paragraph>
                  <paragraph>1 x 0.5 mL Sterile Single-dose Vial – Discard Unused Portion</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do not</content> use the vial if the carton is damaged or if the tamper proof seal is not intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx Only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dicerna</content>
                     <sup>™</sup>
                  </paragraph>
                  <paragraph>a Novo Nordisk company</paragraph>
                  <renderMultiMedia ID="id-692228939" referencedObject="ba3a41a1-9508-4e72-96a8-a4edde68a4bf"/>
               </text>
               <effectiveTime value="20250303"/>
               <component>
                  <observationMedia ID="ba3a41a1-9508-4e72-96a8-a4edde68a4bf">
                     <text>sleeve_80mg</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="sleeve_80mg.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>